These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 23785299)

  • 1. NSAIDs modulate clonal evolution in Barrett's esophagus.
    Kostadinov RL; Kuhner MK; Li X; Sanchez CA; Galipeau PC; Paulson TG; Sather CL; Srivastava A; Odze RD; Blount PL; Vaughan TL; Reid BJ; Maley CC
    PLoS Genet; 2013 Jun; 9(6):e1003553. PubMed ID: 23785299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonsteroidal anti-inflammatory drugs and statins have chemopreventative effects in patients with Barrett's esophagus.
    Kastelein F; Spaander MC; Biermann K; Steyerberg EW; Kuipers EJ; Bruno MJ;
    Gastroenterology; 2011 Dec; 141(6):2000-8; quiz e13-4. PubMed ID: 21878200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evolution of Barrett's esophagus through space and time at single-crypt and whole-biopsy levels.
    Martinez P; Mallo D; Paulson TG; Li X; Sanchez CA; Reid BJ; Graham TA; Kuhner MK; Maley CC
    Nat Commun; 2018 Feb; 9(1):794. PubMed ID: 29476056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NSAIDs modulate CDKN2A, TP53, and DNA content risk for progression to esophageal adenocarcinoma.
    Galipeau PC; Li X; Blount PL; Maley CC; Sanchez CA; Odze RD; Ayub K; Rabinovitch PS; Vaughan TL; Reid BJ
    PLoS Med; 2007 Feb; 4(2):e67. PubMed ID: 17326708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The combination of genetic instability and clonal expansion predicts progression to esophageal adenocarcinoma.
    Maley CC; Galipeau PC; Li X; Sanchez CA; Paulson TG; Blount PL; Reid BJ
    Cancer Res; 2004 Oct; 64(20):7629-33. PubMed ID: 15492292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonsteroidal anti-inflammatory drugs and the esophageal inflammation-metaplasia-adenocarcinoma sequence.
    Anderson LA; Johnston BT; Watson RG; Murphy SJ; Ferguson HR; Comber H; McGuigan J; Reynolds JV; Murray LJ
    Cancer Res; 2006 May; 66(9):4975-82. PubMed ID: 16651456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studying Cancer Evolution in Barrett's Esophagus and Esophageal Adenocarcinoma.
    Paulson TG
    Adv Exp Med Biol; 2016; 908():213-36. PubMed ID: 27573774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of Esophageal Adenocarcinoma Risk Using Somatic Chromosome Alterations in Longitudinal Samples in Barrett's Esophagus.
    Li X; Paulson TG; Galipeau PC; Sanchez CA; Liu K; Kuhner MK; Maley CC; Self SG; Vaughan TL; Reid BJ; Blount PL
    Cancer Prev Res (Phila); 2015 Sep; 8(9):845-56. PubMed ID: 26130253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistent clonal areas and clonal expansion in Barrett's esophagus.
    Raskind WH; Norwood T; Levine DS; Haggitt RC; Rabinovitch PS; Reid BJ
    Cancer Res; 1992 May; 52(10):2946-50. PubMed ID: 1581911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonsteroidal Anti-Inflammatory Drug Use is Not Associated With Reduced Risk of Barrett's Esophagus.
    Thrift AP; Anderson LA; Murray LJ; Cook MB; Shaheen NJ; Rubenstein JH; El-Serag HB; Vaughan TL; Schneider JL; Whiteman DC; Corley DA
    Am J Gastroenterol; 2016 Nov; 111(11):1528-1535. PubMed ID: 27575711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New strategies in Barrett's esophagus: integrating clonal evolutionary theory with clinical management.
    Reid BJ; Kostadinov R; Maley CC
    Clin Cancer Res; 2011 Jun; 17(11):3512-9. PubMed ID: 21498395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NSAID use and somatic exomic mutations in Barrett's esophagus.
    Galipeau PC; Oman KM; Paulson TG; Sanchez CA; Zhang Q; Marty JA; Delrow JJ; Kuhner MK; Vaughan TL; Reid BJ; Li X
    Genome Med; 2018 Feb; 10(1):17. PubMed ID: 29486792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aberrant methylation of secreted frizzled-related protein genes in esophageal adenocarcinoma and Barrett's esophagus.
    Zou H; Molina JR; Harrington JJ; Osborn NK; Klatt KK; Romero Y; Burgart LJ; Ahlquist DA
    Int J Cancer; 2005 Sep; 116(4):584-91. PubMed ID: 15825175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surveillance in Barrett's esophagus: an audit of practice.
    Ajumobi A; Bahjri K; Jackson C; Griffin R
    Dig Dis Sci; 2010 Jun; 55(6):1615-21. PubMed ID: 19669878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bacterial Composition of the Human Upper Gastrointestinal Tract Microbiome Is Dynamic and Associated with Genomic Instability in a Barrett's Esophagus Cohort.
    Gall A; Fero J; McCoy C; Claywell BC; Sanchez CA; Blount PL; Li X; Vaughan TL; Matsen FA; Reid BJ; Salama NR
    PLoS One; 2015; 10(6):e0129055. PubMed ID: 26076489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Demonstration of clonal heterogeneity in adenocarcinomas on Barrett's esophagus by flow cytometric study of cellular DNA content].
    Robaszkiewicz M; Volant A; Hardy E; Nousbaum JB; Calament G; Cauvin JM; Bail JP; Lozach P; Gouerou H
    Gastroenterol Clin Biol; 1992; 16(6-7):540-6. PubMed ID: 1526415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA expression signatures during malignant progression from Barrett's esophagus to esophageal adenocarcinoma.
    Wu X; Ajani JA; Gu J; Chang DW; Tan W; Hildebrandt MA; Huang M; Wang KK; Hawk E
    Cancer Prev Res (Phila); 2013 Mar; 6(3):196-205. PubMed ID: 23466817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular genetic analysis of surveillance biopsy samples from Barrett's mucosa--significance of sampling.
    Werther M; Saure C; Pahl R; Schorr F; Rüschoff J; Alles JU; Heinmöller E
    Pathol Res Pract; 2008; 204(5):285-94. PubMed ID: 18337019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors, DNA damage, and disease progression in Barrett's esophagus.
    Olliver JR; Hardie LJ; Gong Y; Dexter S; Chalmers D; Harris KM; Wild CP
    Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):620-5. PubMed ID: 15767340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chromosomal abnormalities and novel disease-related regions in progression from Barrett's esophagus to esophageal adenocarcinoma.
    Akagi T; Ito T; Kato M; Jin Z; Cheng Y; Kan T; Yamamoto G; Olaru A; Kawamata N; Boult J; Soukiasian HJ; Miller CW; Ogawa S; Meltzer SJ; Koeffler HP
    Int J Cancer; 2009 Nov; 125(10):2349-59. PubMed ID: 19670330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.